Unser Fachwissen teilen
.png?width=1440&height=511&name=Header_Knowledge%20(1).png)
Mehr erfahren
Knowledge Base
Unsere Webinare und Whitepapers
Entdecken Sie unsere wachsende Bibliothek mit von Experten geführten Webinaren und ausführlichen Whitepapers. Dieser Bereich unterstreicht das Engagement von BioSpring für den Wissensaustausch und das kontinuierliche Lernen innerhalb der wissenschaftlichen Gemeinschaft. Ganz gleich, ob Sie Ihr technisches Verständnis vertiefen oder sich über neue Entwicklungen auf dem Laufenden halten möchten, unsere kuratierten Ressourcen bieten wertvolle Perspektiven, die Sie informieren und inspirieren.
Webinare
Regulatory Feedback On Late-Stage Programs - A CDMO Perspective
Advancing an oligonucleotide therapeutic into late-stage development presents unique challenges, requiring a well-defined regulatory and validation strategy. This talk provides key insights from a CDMO perspective on molecule classification, process validation steps, regulatory expectations, and the role of release specifications. Additionally, it highlights best practices for analytical method validation tailored to Phase III and commercial programs, ensuring regulatory compliance and product success.

Whitepapers
Enabling Therapeutic Progress with Oligonucleotide Bioanalysis
Whether you are seeking regulatory approval, evaluating
drug metabolism, or planning your next clinical phase, it is
crucial to have reliable data when analyzing oligonucleotidebased drugs and their metabolites in biofluids and tissues.
Oligonucleotides like ASOs, siRNAs, and guide RNAs
bring unique challenges: diverse chemical modifications
and conjugations, complex degradation pathways, and
interfering sample background make standard bioanalytical
methods unreliable or insufficient. Accurate bioanalysis
requires tailored analytical strategies that account for this
complexity.
This paper explores how you can:
- Navigate the bioanalytical challenges of oligonucleotide therapeutics through strategic method selection
- Evaluate key quantification techniques, including hELISA, qPCR, and LC-MS/MS
- Benefit from BioSpring's tailored LC-MS/MS method using isobaric internal standards, designed to deliver high sensitivity specificity, and reproducibility across various oligonucleotide types in different biofluids and tissues
Mehr entdecken
Erkunden Sie weitere Inhalte
Hier geht es weiter:
Flyer & Broschüren, Poster & Publikationen, Oligos in Aktion, FAQ